Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. - Wikidata - wikimedia - TriplyDB

Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.

Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.

http://www.wikidata.org/entity/Q33632161

about

Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes Hepatoprotective effect of MMP-19 deficiency in a mouse model of chronic liver fibrosis The Discovery and Early Days of TGF-β: A Historical Perspective The emergence of ErbB2 expression in cultured rat hepatocytes correlates with enhanced and diversified EGF-mediated signaling A fresh look at augmenter of liver regeneration in rats An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice Autocrine expression of activated transforming growth factor-beta(1) induces apoptosis in normal rat liver.Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism.Changes in growth factor and cytokine expression in biliary obstructed rat liver and their relationship with delayed liver regeneration after partial hepatectomy.Activin betaC and betaE genes are not essential for mouse liver growth, differentiation, and regeneration.Hepatic hyperplasia associated with discordant xenogeneic parenchymal-nonparenchymal interactions in human hepatocyte-repopulated mice.Biology of transforming growth factor beta in hepatocarcinogenesis.Heparin-binding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration.Differential regulation of multiple gap junction transcripts and proteins during rat liver regeneration.Principles of liver regeneration and growth homeostasis.Role of transforming growth factor beta signaling and expansion of progenitor cells in regenerating liver.Cytosolic phospholipase A2alpha and peroxisome proliferator-activated receptor gamma signaling pathway counteracts transforming growth factor beta-mediated inhibition of primary and transformed hepatocyte growth Mouse hepatic oval cells require Met-dependent PI3K to impair TGF-β-induced oxidative stress and apoptosis.Specific activin receptor-like kinase 3 inhibitors enhance liver regeneration Perspectives in cancer chemoprevention.The mystery of liver regeneration.Attenuation of CCl4-induced hepatic fibrosis in mice by vaccinating against TGF-β1 Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury.Biological Significance of Local TGF-β Activation in Liver Diseases.Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation.Suppression of tumour development by substances derived from the diet--mechanisms and clinical implications.Timing of hepatocyte entry into DNA synthesis after partial hepatectomy is cell autonomous.Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis Fibroblast Growth Factor Signaling Controls Liver Size in Mice With Humanized Livers Regulation of liver regeneration by growth factors and cytokines.Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice.BMP4 is a novel paracrine inhibitor of liver regeneration.In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis Membrane biochemistry and chemical hepatocarcinogenesis.Role of ischaemic preconditioning in liver regeneration following major liver resection and transplantation Transforming growth factor-beta (TGF-beta) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-beta Reticulon 4B (Nogo-B) facilitates hepatocyte proliferation and liver regeneration in mice Liver regeneration: an overview.

P2860

Q24302428-B0DDE25A-FE17-4D38-A083-07E20499DFA1 Q26772317-EF0ACC69-83B6-4926-BB41-EE8CB8E053D7 Q27316480-19493B08-E322-4BB2-AB05-8340FA7D4C7D Q28276556-BB6A9DFC-8A6D-49AB-95B4-01022A3D6775 Q28564678-22B46901-F63C-41FA-8AB6-01EB49092018 Q28580301-1B0AD25F-DC9C-4087-A56B-099767CA8000 Q30449823-696C7DB4-F954-405E-B234-7C599D74521E Q31721830-2BAEAE5E-14D2-4D36-B969-9BAAB0FA5C76 Q33583459-40C0D01B-EFB8-4E4B-B844-57834BA4631F Q33840317-6A3616EE-9BF2-496B-A155-62E0DD14220D Q33867282-AF9258D2-C3A9-49F6-9401-45B185A03FB9 Q33965100-CC488D3B-B160-4759-BADF-DA680288C8BA Q34033544-836E7E6F-1B19-4CA6-BA9C-00221AD918CD Q34136515-B0484E9B-5527-4BE2-93F0-667286C09FD2 Q34307150-12945F3D-E522-4782-834E-B93967A7755C Q34343913-D96CFD81-9EF9-412F-BF8B-0359066E71A4 Q34347580-D9994367-CB37-40EF-BB05-D03EE22212EA Q34402328-546E69E1-ECFD-49D4-B518-5330C548940E Q34455310-53EC2079-0CCB-466D-9B88-F739973B030F Q34542329-DD685CCE-7A47-4215-BB52-CE128AA89251 Q34573900-AC20427E-FFD6-484E-A35C-536254A23E91 Q34638729-94FA4A89-45DD-4923-A21E-334B8EEA1D38 Q34792144-4A1A9A9B-1054-47FA-A56D-9321F526AF09 Q35070050-AC6F4642-6448-4715-9CBE-32CF9113216E Q35597135-F8B1F7FB-C1AB-4FF7-B92D-08CB395E5718 Q35750103-7B8BC7B9-7C64-4937-A332-9BFE130D2675 Q35750826-54A029F0-9E2C-4B79-AA3F-B5710EE22ACD Q35803133-0A82CAA1-9DDF-4368-85E8-D91F2BB9C0FC Q35819402-F3C1DEB0-149D-49B1-B9DE-13222D67040F Q35975984-AAFCEAD6-ACB5-4ACD-B141-483C3B16E6B9 Q35998475-89073ADE-5A0C-449D-BD14-1E5A4F205D48 Q36039310-75761C87-F8A8-4111-BE22-C3A28B1F7BE7 Q36287478-D633B9BA-EA99-4A0B-B8FE-3ABA35DABCC4 Q36494369-17EB0D03-B86A-4EB8-AE19-F431F7651A8A Q36553502-F80E3F88-0D22-47FD-8AAC-7759DDDDFFF8 Q36727744-408FF341-ABB3-4A1E-918F-4E6D5B11DEC5 Q36728101-2302F5AF-7EC2-4F26-A4AC-3AA2E63F5525 Q36745193-9521B948-40A8-4037-8733-D71A687EE303 Q36773990-9988A88C-3414-4B04-BF87-2DE6A0837063 Q36933264-A05A020D-6E94-4C11-8749-E0FFCF2C8D0E

P2860

Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.

http://www.wikidata.org/entity/Q33632161

description

1988 nî lūn-bûn

@nan

1988 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1988 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

name

Type beta transforming growth ...... artial hepatectomy in the rat.

@ast

Type beta transforming growth ...... artial hepatectomy in the rat.

@en

type

label

Type beta transforming growth ...... artial hepatectomy in the rat.

@ast

Type beta transforming growth ...... artial hepatectomy in the rat.

@en

prefLabel

Type beta transforming growth ...... artial hepatectomy in the rat.

@ast

Type beta transforming growth ...... artial hepatectomy in the rat.

@en

P1433

Q33632161-FE8046A9-549B-460B-B926-EAB3D8CA7F67

P1476

Q33632161-2D18F70C-0E4C-450D-9FD8-A6C157C4C0BA

P2093

Q33632161-3A674745-68BA-4678-8BCB-88C808F81053

Q33632161-3FD88069-E341-4ADC-8EA9-6B8D8A098C41

Q33632161-4FD02A35-29C2-4654-963F-345B8A343C88

Q33632161-FD56FA89-0639-4EC1-9624-4821510083E5

P2860

Q33632161-03DD43F5-5089-41C5-90E5-B2CF76F1BFC6

Q33632161-04B58976-9856-4D7B-9D4C-E05DCA404FCE

Q33632161-0798D5C2-62D6-4358-9D4A-D00EDE8A91D6

Q33632161-0E7613A0-0FE2-46CC-B0DE-4F10B43F75CE

Q33632161-10EA8119-45F1-432D-A496-34ED08908E87

Q33632161-11266338-8750-4E43-9556-6065389F8C8A

Q33632161-1A4ADB39-B266-408B-A82D-ECB712CB5469

Q33632161-1D73560D-6AB8-4AB9-ABEF-9D7A699F7C64

Q33632161-35050B28-C9AE-48FC-ACBD-D5A18596BE2D

Q33632161-3801F490-439C-454B-8369-DA4B4DCB0CCE

P304

Q33632161-38E9C3CC-2CA9-46FB-821B-8D41A2C154E6

P31

Q33632161-35D732DD-5E9C-419E-B7B5-185B1D556583

P356

Q33632161-3C0B1761-3C2B-4F18-87FA-1082FA93BC2B

P407

Q33632161-6A8884A9-2B3A-4332-B547-A612D7F3515E

P433

Q33632161-87D4FBED-D4C0-444C-91FC-E0FF7EFE8FDF

P478

Q33632161-EE38697F-14B9-4CF9-B0C5-A92CAA8E6FA6

P577

Q33632161-06DEAE13-E22C-4D3F-85BF-2833D501A445

P5875

Q33632161-E2D6C695-9958-4F02-9456-999D6A4C4735

P698

Q33632161-3E88D133-EB8A-4F96-9ACD-014E5B4F3E69

P921

Q33632161-F27AC7B4-CBEB-41A7-B09F-59FEEE508866

P932

Q33632161-23898194-499F-4A49-9FA0-CF899345FC0B

P356

PNAS.85.14.5126

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Type beta transforming growth ...... artial hepatectomy in the rat.

@en

P2093

A J Ouellette

http://www.w3.org/2001/XMLSchema#string

H L Moses

http://www.w3.org/2001/XMLSchema#string

R J Coffey

http://www.w3.org/2001/XMLSchema#string

W E Russell

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells

Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation.

Complete amino acid sequence of human transforming growth factor type beta 2.

Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism, and biliary excretion

Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells.

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

Serum contains a platelet-derived transforming growth factor.

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.

New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues

Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay.

P304

5126-5130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.85.14.5126

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

1988-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19991155

http://www.w3.org/2001/XMLSchema#string

P698

3164865

http://www.w3.org/2001/XMLSchema#string

P921

P932

281701

http://www.w3.org/2001/XMLSchema#string